Seeking Alpha

More on Stryker (SYK): Q4 beats on both EPS and revenue estimates on a 4.2% Y/Y increase in...

More on Stryker (SYK): Q4 beats on both EPS and revenue estimates on a 4.2% Y/Y increase in sales. Net profit fell 33% Y/Y on hefty charges related to a product recall, while sales continued to strengthen. Neuro-technology and Spine net sales increased 9.7% Y/Y, with its reconstructive segment growing by 6.7% over the same period.

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs